Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry G M Heijerman

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Respiratory Medicine|January 2, 2022
The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trialLotte C Terpstra, Josje Altenburg, Firdaus A Mohamed Hoesein, et al.
Pediatric Pulmonology|May 24, 2023
Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung diseaseBente L Aalbers, Firdaus A A Mohamed Hoesein, Regina W Hofland, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Colistin methanesulfonate infusion solutions are stable over time and suitable for home administrationTitiaan E Post, Ingrid M C Kamerling, Richard C J M van Rossen, et al.
Pediatric Pulmonology|August 9, 2019
Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and coughJennifer J Meerburg, Mehdi Albasri, Els C van der Wiel, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover studyAnnelies J van Velzen, Joris W F Uges, Harry G M Heijerman, et al.
JHLT Open|March 27, 2025
Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study, Johanna P van Gemert, Bart Luijk, et al.
Journal of Personalized Medicine|April 30, 2021
Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N MutationMaartje I Kristensen, Karin M de Winter-de Groot, Gitte Berkers, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 21, 2021
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patientsRenate Kos, Paul Brinkman, Anne H Neerincx, et al.
The European Respiratory Journal|October 11, 2015
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosisJ Stuart Elborn, Scott C Bell, Susan L Madge, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 19, 2019
Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutationsKarin M de Winter-de Groot, Gitte Berkers, Rozemarijn E P Marck-van der Wilt, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Respiratory Medicine|January 2, 2022
The effect of maintenance azithromycin on radiological features in patients with bronchiectasis - Analysis from the BAT randomized controlled trialLotte C Terpstra, Josje Altenburg, Firdaus A Mohamed Hoesein, et al.
Pediatric Pulmonology|May 24, 2023
Radiological and long-term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung diseaseBente L Aalbers, Firdaus A A Mohamed Hoesein, Regina W Hofland, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 4, 2019
Colistin methanesulfonate infusion solutions are stable over time and suitable for home administrationTitiaan E Post, Ingrid M C Kamerling, Richard C J M van Rossen, et al.
Pediatric Pulmonology|August 9, 2019
Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and coughJennifer J Meerburg, Mehdi Albasri, Els C van der Wiel, et al.
British Journal of Clinical Pharmacology|May 22, 2019
Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover studyAnnelies J van Velzen, Joris W F Uges, Harry G M Heijerman, et al.
JHLT Open|March 27, 2025
Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study, Johanna P van Gemert, Bart Luijk, et al.
Journal of Personalized Medicine|April 30, 2021
Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N MutationMaartje I Kristensen, Karin M de Winter-de Groot, Gitte Berkers, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 21, 2021
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patientsRenate Kos, Paul Brinkman, Anne H Neerincx, et al.
The European Respiratory Journal|October 11, 2015
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosisJ Stuart Elborn, Scott C Bell, Susan L Madge, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 19, 2019
Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutationsKarin M de Winter-de Groot, Gitte Berkers, Rozemarijn E P Marck-van der Wilt, et al.
Pageof 5